Generic Injectables Market: Global Market Size, Forecast, Insights, and Competitive Landscape

The global generic injectable market is expected to grow at a CAGR of around 8.2% during 2021-2027. This report on global generic injectable market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global generic injectable market by segmenting the market based on therapeutic area, containers, distribution channel, and region. Also, detailed profiles of companies operating in the generic injectable market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.

Market Drivers

• Government Taking Initiatives to Support Manufacture in Various Countries
• Aging Population and Rising Prevalence of Chronic Diseases
• Cheaper and Shorter R&D

Market Challenges

• Contamination Concerns for Injectable Manufactured in Factories in Some Countries

Historical & Forecast Period

Base Year: 2020
Historical Period: 2016-2019
Forecast Period: 2021-2027

Market by Therapeutic Area

• Oncology
• Anaesthesia
• Anti-infective
• Parenteral Nutrition
• Cardiovascular Diseases

Market by Containers

• Vials
• Ampoules
• Premix
• Prefilled Syringes

Market by Distribution Channel

• Hospitals
• Retail Pharmacy

Market by Region

• Europe
  o Germany
  o United Kingdom
  o France
  o Italy
  o Spain
  o Russia
  o Netherlands
  o Rest of Europe
• North America
  o United States
  o Canada
• Asia Pacific
  o China
  o Japan
  o India
  o South Korea
  o Australia
  o Indonesia
  o Rest of Asia Pacific
• Latin America
  o Mexico
  o Brazil
  o Argentina
  o Rest of Latin America
• Middle East & Africa
  o Saudi Arabia
  o Turkey
  o Iran
  o Rest of Middle East & Africa

1. Preface
1.1 Objective
1.2 Target Audience & Key Offerings
1.3 Report’s Scope
1.4 Research Methodology
1.4.1 Phase I
1.4.2 Phase II
1.4.3 Phase III
1.5 Assumptions
2. Key Insights
3. Global Generic Injectable Market
3.1. Introduction
3.2. Market Drivers
3.3. Market Challenges
4. Global Generic Injectable Market Analysis
4.1. Market Portraiture
4.2. Market Size
4.3. Market Forecast
4.4. Impact of COVID-19
5. Global Generic Injectable Market by Therapeutic Area
5.1. Introduction
5.2. Oncology
5.3. Anaesthesia
5.4. Anti-infective
5.5. Parenteral Nutrition
5.6. Cardiovascular Diseases
6. Global Generic Injectable Market by Containers
6.1. Introduction
6.2. Vials
6.3. Ampoules
6.4. Premix
6.5. Prefilled Syringes
7. Global Generic Injectable Market by Distribution Channel
7.1. Introduction
7.2. Hospitals
7.3. Retail Pharmacy
8. Global Generic Injectable Market by Region
8.1 Introduction
8.2 Europe
8.2.1 Germany
8.2.2 United Kingdom
8.2.3 France
8.2.4 Italy
8.2.5 Spain
8.2.6 Russia
8.2.7 Netherlands
8.2.8 Rest of the Europe
8.3 North America
8.3.1 United States
8.3.2 Canada
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 South Korea
8.4.5 Australia
8.4.6 Indonesia
8.4.7 Rest of the Asia Pacific
8.5 Latin America
8.5.1 Mexico
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Rest of Latin America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 Turkey
8.6.3 Iran
8.6.4 Rest of Middle East & Africa
9. SWOT Analysis
10. Porter’s Five Forces
11. Market Value Chain Analysis
12. Competitive Landscape
12.1 Competitive Scenario
12.2 Company Profiles
12.2.1 Hospira (Pfizer)
12.2.2 Fresenius Kabi
12.2.3 Hikma Pharma PLC
12.2.4 Sandoz (Novartis)
12.2.5 Sagent Inc.
12.2.6 Sanofi
12.2.7 Baxter
12.2.8 Dr. Reddy Laboratories
12.2.9 Akorn Inc.
12.2.10 Fresenius SE & Co. KGaA
12.2.11 Mylan N.V.
12.2.12 Teva Pharmaceutical Industries Ltd
12.2.13 Lupin Ltd
12.2.14 Aurobindo Pharma
12.2.15 Biocon

List of Figures

Figure 1: Global Generic Injectable Market (in US$ Million), 2016-2020
Figure 2: Global Generic Injectable Market by Therapeutic Area, 2020
Figure 3: Global Generic Injectable Market by Containers, 2020
Figure 4: Global Generic Injectable Market by Distribution Channel, 2020
Figure 5: Global Generic Injectable Market by Region, 2020
Figure 6: Global Generic Injectable Market (in US$ Million), 2021-2027
Figure 7: Global Generic Injectable Market by Therapeutic Area (in %), 2020 & 2027
Figure 8: Global Oncology Generic Injectable Market (in US$ Million), 2016-2020
Figure 9: Global Oncology Generic Injectable Market (in US$ Million), 2021-2027
Figure 10: Global Anaesthesia Generic Injectable Market (in US$ Million), 2016-2020
Figure 11: Global Anaesthesia Generic Injectable Market (in US$ Million), 2021-2027
Figure 12: Global Anti-infective Generic Injectable Market (in US$ Million), 2016-2020
Figure 13: Global Anti-infective Generic Injectable Market (in US$ Million), 2021-2027
Figure 14: Global Parenteral Nutrition Generic Injectable Market (in US$ Million), 2016-2020
Figure 15: Global Parenteral Nutrition Generic Injectable Market (in US$ Million), 2021-2027
Figure 16: Global Cardiovascular Diseases Generic Injectable Market (in US$ Million), 2016-2020
Figure 17: Global Cardiovascular Diseases Generic Injectable Market (in US$ Million), 2021-2027
Figure 18: Global Generic Injectable Market by Containers (in %), 2020 & 2027
Figure 19: Global Vials Generic Injectable Market (in US$ Million), 2016-2020
Figure 20: Global Vials Generic Injectable Market (in US$ Million), 2021-2027
Figure 21: Global Ampoules Generic Injectable Market (in US$ Million), 2016-2020
Figure 22: Global Ampoules Generic Injectable Market (in US$ Million), 2021-2027
Figure 23: Global Premix Generic Injectable Market (in US$ Million), 2016-2020
Figure 24: Global Premix Generic Injectable Market (in US$ Million), 2021-2027
Figure 25: Global Prefilled Syringes Generic Injectable Market (in US$ Million), 2016-2020
Figure 26: Global Prefilled Syringes Generic Injectable Market (in US$ Million), 2021-2027
Figure 27: Global Generic Injectable Market by Distribution Channel (in %), 2020 & 2027
Figure 28: Global Hospitals Generic Injectable Market (in US$ Million), 2016-2020
Figure 29: Global Hospitals Generic Injectable Market (in US$ Million), 2021-2027
Figure 30: Global Retail Pharmacy Generic Injectable Market (in US$ Million), 2016-2020
Figure 31: Global Retail Pharmacy Generic Injectable Market (in US$ Million), 2021-2027
Figure 32: Global Generic Injectable Market by Region (in %), 2020 & 2027
Figure 33: Europe Generic Injectable Market (in US$ Million), 2016-2020
Figure 34: Europe Generic Injectable Market (in US$ Million), 2021-2027
Figure 35: Europe Generic Injectable Market by Country (in %), 2020 & 2027
Figure 36: Germany Generic Injectable Market (in US$ Million), 2016-2027
Figure 37: United Kingdom Generic Injectable Market (in US$ Million), 2016-2027
Figure 38: France Generic Injectable Market (in US$ Million), 2016-2027
Figure 39: Italy Generic Injectable Market (in US$ Million), 2016-2027
Figure 40: Spain Generic Injectable Market (in US$ Million), 2016-2027
Figure 41: Russia Generic Injectable Market (in US$ Million), 2016-2027
Figure 42: Netherlands Generic Injectable Market (in US$ Million), 2016-2027
Figure 43: North America Generic Injectable Market (in US$ Million), 2016-2020
Figure 44: North America Generic Injectable Market (in US$ Million), 2021-2027
Figure 45: North America Generic Injectable Market by Country (in %), 2020 & 2027
Figure 46: United States Generic Injectable Market (in US$ Million), 2016-2027
Figure 47: Canada Generic Injectable Market (in US$ Million), 2016-2027
Figure 48: Asia Pacific Generic Injectable Market (in US$ Million), 2016-2020
Figure 49: Asia Pacific Generic Injectable Market (in US$ Million), 2021-2027
Figure 50: Asia Pacific Generic Injectable Market by Country (in %), 2020 & 2027
Figure 51: China Generic Injectable Market (in US$ Million), 2016-2027
Figure 52: Japan Generic Injectable Market (in US$ Million), 2016-2027
Figure 53: India Generic Injectable Market (in US$ Million), 2016-2027
Figure 54: South Korea Generic Injectable Market (in US$ Million), 2016-2027
Figure 55: Australia Generic Injectable Market (in US$ Million), 2016-2027
Figure 56: Indonesia Generic Injectable Market (in US$ Million), 2016-2027
Figure 57: Latin America Generic Injectable Market (in US$ Million), 2016-2020
Figure 58: Latin America Generic Injectable Market (in US$ Million), 2021-2027
Figure 59: Latin America Generic Injectable Market by Country (in %), 2020 & 2027
Figure 60: Mexico Generic Injectable Market (in US$ Million), 2016-2027
Figure 61: Brazil Generic Injectable Market (in US$ Million), 2016-2027
Figure 62: Argentina Generic Injectable Market (in US$ Million), 2016-2027
Figure 63: Middle East & Africa Generic Injectable Market (in US$ Million), 2016-2020
Figure 64: Middle East & Africa Generic Injectable Market (in US$ Million), 2021-2027
Figure 65: Middle East & Africa Generic Injectable Market by Country (in %), 2020 & 2027
Figure 66: Saudi Arabia Generic Injectable Market (in US$ Million), 2016-2027
Figure 67: Turkey Generic Injectable Market (in US$ Million), 2016-2027
Figure 68: Iran Generic Injectable Market (in US$ Million), 2016-2027
Figure 69: Market Value Chain

List of Tables

Table 1: Global Generic Injectable Market Portraiture
Table 2: Global Generic Injectable Market by Therapeutic Area (in US$ Million), 2020 & 2027
Table 3: Global Generic Injectable Market by Containers (in US$ Million), 2020 & 2027
Table 4: Global Generic Injectable Market by Distribution Channel (in US$ Million), 2020 & 2027
Table 5: Global Generic Injectable Market by Region (in US$ Million), 2020 & 2027
Table 6: Europe Generic Injectable Market by Country (in US$ Million), 2020 & 2027
Table 7: North America Generic Injectable Market by Country (in US$ Million), 2020 & 2027
Table 8: Asia Pacific Generic Injectable Market by Country (in US$ Million), 2020 & 2027
Table 9: Latin America Generic Injectable Market by Country (in US$ Million), 2020 & 2027
Table 10: Middle East & Africa Generic Injectable Market by Country (in US$ Million), 2020 & 2027
Table 11: List of Key Players